Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram for Neuroplasticity in Stroke
NCT04221256Phase 2Withdrawn
- Sponsor
- Burke Neurological Institute
- Start
- Mar 2020
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of escitalopram in ischemic stroke, sponsored by Burke Neurological Institute. Planned start Mar 2020; status: withdrawn.
02
Drugs
escitalopram
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04221256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04221256.